Exact Sciences Corporation (EXAS) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Zanotti Katherine S avec 75,966 actions. Parmi les autres détenteurs notables Paulsen Gisela et Doyle James Edward.
Au cours des 12 derniers mois, les initiés ont effectué 43 transactions sur EXAS l'action — 19 achats (d'une valeur de $13.89K) et 1 ventes (d'une valeur de $170.61K). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
EXAS Participations des Initiés
Principal Actionnaire
Zanotti Katherine S
75,966 actions
Achats (12 mois)
19
$13.89K valeur
Ventes (12 mois)
1
$170.61K valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Zanotti Katherine S |
Director |
75,966 |
2025-06-16 |
|
| 2 |
Paulsen Gisela |
Gen Mgr, Precision Oncology |
66,267 |
2020-04-22 |
|
| 3 |
Doyle James Edward |
Director |
61,447 |
2025-06-16 |
|
| 4 |
Coward D Scott |
Director |
57,562 |
2025-06-16 |
|
| 5 |
Cunningham Everett |
Chief Commercial Officer |
46,470 |
2024-05-02 |
|
| 6 |
Orville Jacob A |
EVP, GM, Screening |
38,707 |
2026-02-27 |
|
| 7 |
Lidgard Graham Peter |
Chief Science Officer |
34,891 |
2021-03-10 |
|
| 8 |
Levangie Daniel J |
Director |
34,312 |
2025-06-16 |
|
| 9 |
Sebelius Kathleen |
Director |
32,671 |
2024-12-20 |
|
| 10 |
Bloomer Aaron |
EVP, Chief Financial Officer |
28,063 |
2026-02-27 |
|
| 11 |
Baranick Brian |
EVP, GM, Precision Oncology |
28,063 |
2026-02-27 |
|
| 12 |
Clancy Paul J |
Director |
26,038 |
2025-06-16 |
|
| 13 |
Stenhouse Mark |
President, Cologuard |
25,000 |
2020-04-06 |
|
| 14 |
Jacquet Pierre |
Director |
23,576 |
2023-06-12 |
|
| 15 |
Condella Sarah |
EVP, Human Resources |
23,224 |
2026-02-27 |
|
| 16 |
Petrovic Shacey |
Director |
21,804 |
2025-06-16 |
|
| 17 |
Herriott James |
SVP, General Counsel & Sec |
20,321 |
2026-02-27 |
|
| 18 |
Lewis-hall Freda C |
Director |
19,688 |
2023-06-12 |
|
| 19 |
Conroy Kevin T |
President and CEO |
18,143 |
2026-03-03 |
|
| 20 |
Trigg Leslie |
Director |
17,169 |
2025-06-16 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-23 |
Bloomer Aaron |
EVP, Chief Financial Officer |
Restitution d'Actions |
28,063 |
- |
- |
| 2026-03-23 |
Herriott James |
SVP, General Counsel & Sec |
Restitution d'Actions |
20,321 |
- |
- |
| 2026-03-23 |
Baranick Brian |
EVP, GM, Precision Oncology |
Restitution d'Actions |
28,063 |
- |
- |
| 2026-03-23 |
Barber Michael J |
Director |
Restitution d'Actions |
7,422 |
- |
- |
| 2026-03-23 |
Condella Sarah |
EVP, Human Resources |
Restitution d'Actions |
23,224 |
- |
- |
| 2026-03-23 |
Petrovic Shacey |
Director |
Restitution d'Actions |
7,095 |
$0.01 |
$70.95 |
| 2026-03-23 |
Doyle James Edward |
Director |
Restitution d'Actions |
5,398 |
- |
- |
| 2026-03-23 |
Clancy Paul J |
Director |
Restitution d'Actions |
5,398 |
- |
- |
| 2026-03-23 |
Zanotti Katherine S |
Director |
Restitution d'Actions |
5,398 |
- |
- |
| 2026-03-23 |
Popovits Kimberly J |
Director |
Restitution d'Actions |
9,656 |
- |
- |
| 2026-03-23 |
Conroy Kevin T |
President and CEO |
Restitution d'Actions |
154,829 |
- |
- |
| 2026-03-23 |
Trigg Leslie |
Director |
Restitution d'Actions |
13,925 |
- |
- |
| 2026-03-23 |
Orville Jacob A |
EVP, GM, Screening |
Restitution d'Actions |
38,707 |
- |
- |
| 2026-03-23 |
Coward D Scott |
Director |
Restitution d'Actions |
12,875 |
$98.18 |
$1.26M |
| 2026-02-27 |
Condella Sarah |
EVP, Human Resources |
Exercice d'Options (Vente) |
3,900 |
$5.03 |
$19.62K |
| 2026-02-27 |
Conroy Kevin T |
President and CEO |
Exercice d'Options (Vente) |
18,143 |
- |
- |
| 2026-02-25 |
Bloomer Aaron |
EVP, Chief Financial Officer |
Attribution de RSU |
28,063 |
- |
- |
| 2026-02-25 |
Herriott James |
SVP, General Counsel & Sec |
Attribution de RSU |
20,321 |
- |
- |
| 2026-02-25 |
Baranick Brian |
EVP, GM, Precision Oncology |
Attribution de RSU |
28,063 |
- |
- |
| 2026-02-25 |
Condella Sarah |
EVP, Human Resources |
Attribution de RSU |
23,224 |
- |
- |
| 2026-02-25 |
Conroy Kevin T |
President and CEO |
Attribution de RSU |
154,829 |
- |
- |
| 2026-02-25 |
Orville Jacob A |
EVP, GM, Screening |
Attribution de RSU |
38,707 |
- |
- |
| 2025-12-24 |
Baranick Brian |
EVP, GM, Precision Oncology |
Retenue Fiscale RSU |
14,938 |
$101.59 |
$1.52M |
| 2025-12-23 |
Baranick Brian |
EVP, GM, Precision Oncology |
Exercice d'Options |
9,450 |
- |
- |
| 2025-12-23 |
Orville Jacob A |
EVP, GM, Screening |
Exercice d'Options (Vente) |
16,051 |
- |
- |
Les autres consultent aussi
